Skip to main content
Top
Published in: BMC Medical Genetics 1/2019

Open Access 01-12-2019 | Research article

Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations

Authors: Qi Yang, Sheng Yi, Mengting Li, Bobo Xie, Jinsi Luo, Jin Wang, Xiuliang Rong, Qinle Zhang, Zailong Qin, Limei Hang, Shihan Feng, Xin Fan

Published in: BMC Medical Genetics | Issue 1/2019

Login to get access

Abstract

Background

Oculocutaneous albinism (OCA) is a human autosomal-recessive hypopigmentation disorder with hypopigmentation in the skin, hair, and eyes. OCA1 and OCA2 are caused by mutations of the TYR and OCA2 genes, respectively, which are responsible for most oculocutaneous albinism. However, the incidence of oculocutaneous albinism patients in Guangxi remains unclear.

Methods

To evaluate the molecular basis of oculocutaneous albinism in thirty-six patients in Guangxi, China. Peripheral venous blood samples were collected from these unrelated patients. The TYR and OCA2 genes of all individuals were analyzed by direct DNA sequencing and the sequences compared with are reference database and bioinformatics analysis.

Results

Among the 36 OCA patients, 8(22.2%) were found mutations on TYR gene, 28 (77.8%) on OCA2. And we identified Twenty-seven different TYR and OCA2 mutations in these patients, including one novel TYR framshift mutation c.561_562insTTATTATGTGTCAAATTATCCCCCA, three novel OCA2 mutations: one nonsense mutation c.2195C > G(p.S732X), one deletation mutation(c.1139-1141delTGG), one missense mutations c.2495A > C(p.H832P). The population screening and the bioinformatic analysis to determined the effects of the mutations, which revealed these four novel mutations were pathogenic.

Conclusions

This study expands the mutation spectrum of oculocutaneous albinism. Four novel mutational alleles c.1139-1141delTGG, c.1832 T > C and c.2195C > G and of the OCA2 gene and c.561_562insTTATTATGTGTCAAATTATCCCCCA of TYR were associated with OCA. The genotype–phenotype correlations suggest that molecular diagnosis is more accurate and important in OCA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Justin R. Federico; Karthik Krishnamurthy. Albinism. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2019–2018. Justin R. Federico; Karthik Krishnamurthy. Albinism. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2019–2018.
2.
go back to reference King RA, Olds DP. Hairbulb tyrosinase activity in oculocutaneous albinism: suggestions for pathwaycontrol and block location. Am J Med Genet. 1985;20:49–55.CrossRef King RA, Olds DP. Hairbulb tyrosinase activity in oculocutaneous albinism: suggestions for pathwaycontrol and block location. Am J Med Genet. 1985;20:49–55.CrossRef
4.
go back to reference Gronskov K, Ek J. Oculocutaneous albinism. Orphanet Journal of Rare Diseasea. 2007;2:43.CrossRef Gronskov K, Ek J. Oculocutaneous albinism. Orphanet Journal of Rare Diseasea. 2007;2:43.CrossRef
7.
go back to reference Rooryck C, Morice-Picard F, Elçioglu NH, Lacombe D, Taieb A, Arveiler B. Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects. Pigment Cell & Melanoma Research. 2008;21:583–7.CrossRef Rooryck C, Morice-Picard F, Elçioglu NH, Lacombe D, Taieb A, Arveiler B. Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects. Pigment Cell & Melanoma Research. 2008;21:583–7.CrossRef
8.
go back to reference Inagaki K, Suzuki T, Shimizu H, et al. Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. Am J Hum Genet. 2004;74:466–71.CrossRef Inagaki K, Suzuki T, Shimizu H, et al. Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. Am J Hum Genet. 2004;74:466–71.CrossRef
10.
go back to reference Giebel LB, Strunk KM, Spritz RA. Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment. Genomics. 1991;9:435–45.CrossRef Giebel LB, Strunk KM, Spritz RA. Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment. Genomics. 1991;9:435–45.CrossRef
14.
go back to reference Lee ST, Nicholls RD, Jong MT, Fukai K, Spritz RA. Organization and sequence of the human P gene and identification of a new family of transport proteins. Genomics. 1995;26:354–63.CrossRef Lee ST, Nicholls RD, Jong MT, Fukai K, Spritz RA. Organization and sequence of the human P gene and identification of a new family of transport proteins. Genomics. 1995;26:354–63.CrossRef
15.
go back to reference Brilliant MH. The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. Pigment Cell Res. 2001;14:86–93.CrossRef Brilliant MH. The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. Pigment Cell Res. 2001;14:86–93.CrossRef
17.
go back to reference Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine : official journal of the American College of Medical Genetics. 2015;17:405–24.CrossRef Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine : official journal of the American College of Medical Genetics. 2015;17:405–24.CrossRef
18.
go back to reference Toyofuku K, Wada I, Valencia JC, Kushimoto T, Ferrans VJ, Hearing VJ. Oculocutaneousalbinism types 1 and 3 are ER retention disease: mutation oftyrosinase Tyrp1 can affect the processing of both mutantand wild-type proteins. FASEB J. 2001;15:2149–61.CrossRef Toyofuku K, Wada I, Valencia JC, Kushimoto T, Ferrans VJ, Hearing VJ. Oculocutaneousalbinism types 1 and 3 are ER retention disease: mutation oftyrosinase Tyrp1 can affect the processing of both mutantand wild-type proteins. FASEB J. 2001;15:2149–61.CrossRef
19.
go back to reference Chen K, Manga P, Orlow SJ. Pink-eyed dilution protein controls the processing of tyrosinase. Mol Genet Genomic Med. 2016;4:420–30.CrossRef Chen K, Manga P, Orlow SJ. Pink-eyed dilution protein controls the processing of tyrosinase. Mol Genet Genomic Med. 2016;4:420–30.CrossRef
20.
go back to reference Toyofuku K, Valencia JC, Kushimoto T, Costin GE, Virador VM, Vieira WD, et al. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase. Pigment Cell Res. 2002;15:217–24.CrossRef Toyofuku K, Valencia JC, Kushimoto T, Costin GE, Virador VM, Vieira WD, et al. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase. Pigment Cell Res. 2002;15:217–24.CrossRef
21.
go back to reference Rosemblat S, Durham-Pierre D, Gardner JM, Nakatsu Y, Brilliant MH, Orlow SJ. Identification of a melanosomal membrane protein encoded by the pink-eyed dilution (type II oculocutaneous albinism) gene. Proc Natl Acad Sci U S A. 1994;91:12071–5.CrossRef Rosemblat S, Durham-Pierre D, Gardner JM, Nakatsu Y, Brilliant MH, Orlow SJ. Identification of a melanosomal membrane protein encoded by the pink-eyed dilution (type II oculocutaneous albinism) gene. Proc Natl Acad Sci U S A. 1994;91:12071–5.CrossRef
22.
go back to reference Tripathi RK, Durham-Pierre D, Gardner JM, Nakatsu Y, Brilliant MH, Orlow SJ. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions. Am J Med Genet. 1992;43:865–71.CrossRef Tripathi RK, Durham-Pierre D, Gardner JM, Nakatsu Y, Brilliant MH, Orlow SJ. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions. Am J Med Genet. 1992;43:865–71.CrossRef
23.
go back to reference Tomita Y, Takeda A, Okinaga S, Tagami H, Shibahara S. Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. Biochem Biophys Res Commun. 1989;164:990–6.CrossRef Tomita Y, Takeda A, Okinaga S, Tagami H, Shibahara S. Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. Biochem Biophys Res Commun. 1989;164:990–6.CrossRef
24.
go back to reference Tripathi RK, Strunk KM, Giebel LB, Weleber RG, Spritz RA. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define twoclusters of missense substitutions. Am J Med Genet. 1992;43:865–71.CrossRef Tripathi RK, Strunk KM, Giebel LB, Weleber RG, Spritz RA. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define twoclusters of missense substitutions. Am J Med Genet. 1992;43:865–71.CrossRef
25.
go back to reference Tomita Y, Miyamura Y, Kono M, Nakamura R, Matsunaga J. Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism in Japan. Pigment Cell Res. 2000;8:130–4.CrossRef Tomita Y, Miyamura Y, Kono M, Nakamura R, Matsunaga J. Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism in Japan. Pigment Cell Res. 2000;8:130–4.CrossRef
26.
go back to reference Tsai CH, Tsai FJ, Wu JY, Lin SP, Chang JG, Yang CF, et al. Insertion/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan. Hum Mutat. 1999;14:542.CrossRef Tsai CH, Tsai FJ, Wu JY, Lin SP, Chang JG, Yang CF, et al. Insertion/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan. Hum Mutat. 1999;14:542.CrossRef
28.
go back to reference Boissy RE, Nordlund JJ. Molecular basis of congenital hypopigmentary disorders in humans: a review. Pigment Cell Res. 1997;10:12–24.CrossRef Boissy RE, Nordlund JJ. Molecular basis of congenital hypopigmentary disorders in humans: a review. Pigment Cell Res. 1997;10:12–24.CrossRef
29.
go back to reference Suzuki T, Miyamura Y, Matsunaga J, Shimizu H, Kawachi Y, Ohyama N, et al. Six novel P gene mutations and oculocutaneous albinism type 2 frequency in Japanese albinopatients. J Invest Dermatol. 2003;120:781–3.CrossRef Suzuki T, Miyamura Y, Matsunaga J, Shimizu H, Kawachi Y, Ohyama N, et al. Six novel P gene mutations and oculocutaneous albinism type 2 frequency in Japanese albinopatients. J Invest Dermatol. 2003;120:781–3.CrossRef
31.
go back to reference Oetting WS, Garrett SS, Brott M, King RA. P gene mutations associated with oculocutaneous albinism type II (OCA2). Hum Mutat. 2005;25:323.CrossRef Oetting WS, Garrett SS, Brott M, King RA. P gene mutations associated with oculocutaneous albinism type II (OCA2). Hum Mutat. 2005;25:323.CrossRef
32.
go back to reference Rooryck C, Morice-Picard F, Elçioglu NH, Lacombe D, Taieb A, Arveiler B. Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspec. Pigment Cell Melanoma Res. 2008;21:583–7.CrossRef Rooryck C, Morice-Picard F, Elçioglu NH, Lacombe D, Taieb A, Arveiler B. Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspec. Pigment Cell Melanoma Res. 2008;21:583–7.CrossRef
33.
go back to reference Duan HL, Li HY, Wu WQ, Zheng H, Chen Z. A novel P gene mutation in a Chinese family with oculocutaneous albinism. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006;23:614–7.PubMed Duan HL, Li HY, Wu WQ, Zheng H, Chen Z. A novel P gene mutation in a Chinese family with oculocutaneous albinism. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006;23:614–7.PubMed
34.
go back to reference Suzuki T, Miyamura Y, Tomita Y. High frequency of the Ala481Thr mutation of the P gene in the Japanese population. Am J Med Genet A. 2003;118A:402–3.CrossRef Suzuki T, Miyamura Y, Tomita Y. High frequency of the Ala481Thr mutation of the P gene in the Japanese population. Am J Med Genet A. 2003;118A:402–3.CrossRef
35.
go back to reference Passmore LA, Kaesmann-Kellner B, Weber BH. Novel and recurrent mutations in the tyrosinase gene and the P gene in the German albino population. Hum Genet. 1999;105:200–10.CrossRef Passmore LA, Kaesmann-Kellner B, Weber BH. Novel and recurrent mutations in the tyrosinase gene and the P gene in the German albino population. Hum Genet. 1999;105:200–10.CrossRef
36.
go back to reference Spritz RA, Lee ST, Fukai K, Brondum-Nielsen K, Chitayat D, Lipson MH, Musarella MA, Rosenmann A, Weleber RG. Novel mutations of the P gene in type II oculocutaneous albinism (OCA2). Hum Mutat. 1997;10:175–7.CrossRef Spritz RA, Lee ST, Fukai K, Brondum-Nielsen K, Chitayat D, Lipson MH, Musarella MA, Rosenmann A, Weleber RG. Novel mutations of the P gene in type II oculocutaneous albinism (OCA2). Hum Mutat. 1997;10:175–7.CrossRef
37.
go back to reference Spritz RA. Molecular genetics of oculocutaneous albinism. Hum Mol Genet. 1994;3:1469–75.CrossRef Spritz RA. Molecular genetics of oculocutaneous albinism. Hum Mol Genet. 1994;3:1469–75.CrossRef
38.
go back to reference Yuasa I, Umetsu K, Harihara S, Miyoshi A, Saitou N, Park KS, et al. OCA2 481Thr, a hypofunctional allele in pigmentation, is characteristic of northeastern Asianpopulations. J Hum Genet. 2007;52:690–3.CrossRef Yuasa I, Umetsu K, Harihara S, Miyoshi A, Saitou N, Park KS, et al. OCA2 481Thr, a hypofunctional allele in pigmentation, is characteristic of northeastern Asianpopulations. J Hum Genet. 2007;52:690–3.CrossRef
Metadata
Title
Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations
Authors
Qi Yang
Sheng Yi
Mengting Li
Bobo Xie
Jinsi Luo
Jin Wang
Xiuliang Rong
Qinle Zhang
Zailong Qin
Limei Hang
Shihan Feng
Xin Fan
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2019
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/s12881-019-0842-7

Other articles of this Issue 1/2019

BMC Medical Genetics 1/2019 Go to the issue